Oral Vaccines Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Oral Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Oral Vaccines are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Oral Vaccines market segmented into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others

Based on the end-use, the global Oral Vaccines market classified into
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others

Based on geography, the global Oral Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ORAL VACCINES INDUSTRY
2.1 Summary about Oral Vaccines Industry
2.2 Oral Vaccines Market Trends
2.2.1 Oral Vaccines Production & Consumption Trends
2.2.2 Oral Vaccines Demand Structure Trends
2.3 Oral Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Attenuated Vaccines
4.2.2 Killed/Inactivated Vaccines
4.2.3 Recombinant Vaccines
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Polio
4.3.2 Rabies
4.3.3 Rotavirus
4.3.4 Cholera
4.3.5 HIV
4.3.6 Respiratory Infections
4.3.7 Influenza
4.3.8 Tuberculosis
4.3.9 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Attenuated Vaccines
5.2.2 Killed/Inactivated Vaccines
5.2.3 Recombinant Vaccines
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Polio
5.3.2 Rabies
5.3.3 Rotavirus
5.3.4 Cholera
5.3.5 HIV
5.3.6 Respiratory Infections
5.3.7 Influenza
5.3.8 Tuberculosis
5.3.9 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Attenuated Vaccines
6.2.2 Killed/Inactivated Vaccines
6.2.3 Recombinant Vaccines
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Polio
6.3.2 Rabies
6.3.3 Rotavirus
6.3.4 Cholera
6.3.5 HIV
6.3.6 Respiratory Infections
6.3.7 Influenza
6.3.8 Tuberculosis
6.3.9 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Attenuated Vaccines
7.2.2 Killed/Inactivated Vaccines
7.2.3 Recombinant Vaccines
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Polio
7.3.2 Rabies
7.3.3 Rotavirus
7.3.4 Cholera
7.3.5 HIV
7.3.6 Respiratory Infections
7.3.7 Influenza
7.3.8 Tuberculosis
7.3.9 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Attenuated Vaccines
8.2.2 Killed/Inactivated Vaccines
8.2.3 Recombinant Vaccines
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Polio
8.3.2 Rabies
8.3.3 Rotavirus
8.3.4 Cholera
8.3.5 HIV
8.3.6 Respiratory Infections
8.3.7 Influenza
8.3.8 Tuberculosis
8.3.9 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Attenuated Vaccines
9.2.2 Killed/Inactivated Vaccines
9.2.3 Recombinant Vaccines
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Polio
9.3.2 Rabies
9.3.3 Rotavirus
9.3.4 Cholera
9.3.5 HIV
9.3.6 Respiratory Infections
9.3.7 Influenza
9.3.8 Tuberculosis
9.3.9 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GlaxoSmithKline Plc.
10.1.2 PaxVax Corporation
10.1.3 Pfizer Inc
10.1.4 Merial, Inc.
10.1.5 Merck Sharp & Dohme Corp
10.1.6 VALNEVA Canada Inc.
10.1.7 QUíMICA SUIZA S.A
10.1.8 Immunitor, Inc
10.1.9 Aventis (Sanofi S.A.)
10.1.10 Serum Institute of India Pvt. Ltd
10.1.11 Swiss Serum and Vaccine Institute Berne
10.1.12 Bull Bio - NCIPD Ltd.
10.1.13 Vaxart, Inc.
10.1.14 Shantha Biotechnics
10.1.15 Crucell (Janssen Global Services, LLC)
10.2 Oral Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 GlaxoSmithKline Plc.
10.2.2 PaxVax Corporation
10.2.3 Pfizer Inc
10.2.4 Merial, Inc.
10.2.5 Merck Sharp & Dohme Corp
10.2.6 VALNEVA Canada Inc.
10.2.7 QUíMICA SUIZA S.A
10.2.8 Immunitor, Inc
10.2.9 Aventis (Sanofi S.A.)
10.2.10 Serum Institute of India Pvt. Ltd
10.2.11 Swiss Serum and Vaccine Institute Berne
10.2.12 Bull Bio - NCIPD Ltd.
10.2.13 Vaxart, Inc.
10.2.14 Shantha Biotechnics
10.2.15 Crucell (Janssen Global Services, LLC)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
Table Oral Vaccines Product Type Overview
Table Oral Vaccines Product Type Market Share List
Table Oral Vaccines Product Type of Major Players
Table Brief Introduction of GlaxoSmithKline Plc.
Table Brief Introduction of PaxVax Corporation
Table Brief Introduction of Pfizer Inc
Table Brief Introduction of Merial, Inc.
Table Brief Introduction of Merck Sharp & Dohme Corp
Table Brief Introduction of VALNEVA Canada Inc.
Table Brief Introduction of QUíMICA SUIZA S.A
Table Brief Introduction of Immunitor, Inc
Table Brief Introduction of Aventis (Sanofi S.A.)
Table Brief Introduction of Serum Institute of India Pvt. Ltd
Table Brief Introduction of Swiss Serum and Vaccine Institute Berne
Table Brief Introduction of Bull Bio - NCIPD Ltd.
Table Brief Introduction of Vaxart, Inc.
Table Brief Introduction of Shantha Biotechnics
Table Brief Introduction of Crucell (Janssen Global Services, LLC)
Table Products & Services of GlaxoSmithKline Plc.
Table Products & Services of PaxVax Corporation
Table Products & Services of Pfizer Inc
Table Products & Services of Merial, Inc.
Table Products & Services of Merck Sharp & Dohme Corp
Table Products & Services of VALNEVA Canada Inc.
Table Products & Services of QUíMICA SUIZA S.A
Table Products & Services of Immunitor, Inc
Table Products & Services of Aventis (Sanofi S.A.)
Table Products & Services of Serum Institute of India Pvt. Ltd
Table Products & Services of Swiss Serum and Vaccine Institute Berne
Table Products & Services of Bull Bio - NCIPD Ltd.
Table Products & Services of Vaxart, Inc.
Table Products & Services of Shantha Biotechnics
Table Products & Services of Crucell (Janssen Global Services, LLC)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Oral Vaccines Market Forecast (Million USD) by Region 2021f-2026f
Table Global Oral Vaccines Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Oral Vaccines Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Oral Vaccines Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
Figure Global Oral Vaccines Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Vaccines Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Vaccines Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Vaccines Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Vaccines Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oral Vaccines Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oral Vaccines Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Killed/Inactivated Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polio Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rotavirus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cholera Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure HIV Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Respiratory Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Influenza Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tuberculosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Vaccines Sales Revenue (Million USD) of GlaxoSmithKline Plc. 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of PaxVax Corporation 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Pfizer Inc 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Merial, Inc. 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Merck Sharp & Dohme Corp 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of VALNEVA Canada Inc. 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of QUíMICA SUIZA S.A 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Immunitor, Inc 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Aventis (Sanofi S.A.) 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Serum Institute of India Pvt. Ltd 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Swiss Serum and Vaccine Institute Berne 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Bull Bio - NCIPD Ltd. 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Vaxart, Inc. 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Shantha Biotechnics 2017-2020e
Figure Oral Vaccines Sales Revenue (Million USD) of Crucell (Janssen Global Services, LLC) 2017-2020e

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2021 Worldwide Market Reports. All rights reserved